Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]

  • In development
  • GID-TA10391
  • Expected publication date: TBC
Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators: 21 June to 2 July 2021.